Immune Design

Immune Design

Immune Design

Immune Design develops vaccines and therapeutics for the prevention and treatment of infectious diseases.
Founded
2008
Raised
$99M
Follow us
Alexa global traffic share
Acquired by
Merck
1
21 Feb 2019
$300,000,000
Latest funding Show all
$17,500
Venture capital - 2014
$49,000,000
Venture capital (Series C) - 2013
Osage University Partners Alta Partners Versant Ventures +3
$300,000,000
GeekWire

Seattle biotech Immune Design acquired by drug giant Merck for $300M